2.40
0.00 (0.00%)
Penutupan Terdahulu | 2.40 |
Buka | 2.49 |
Jumlah Dagangan | 24,795 |
Purata Dagangan (3B) | 36,855 |
Modal Pasaran | 18,000,000 |
Harga / Jualan (P/S) | 1.05 |
Harga / Buku (P/B) | 5.31 |
Julat 52 Minggu |
Margin Keuntungan | -1.23% |
Margin Operasi (TTM) | -6.58% |
EPS Cair (TTM) | -0.170 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 17.00% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -99.60% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 723.93% |
Nisbah Semasa (MRQ) | 0.600 |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.22 M |
Pulangan Atas Aset (ROA TTM) | -3.86% |
Pulangan Atas Ekuiti (ROE TTM) | -30.55% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Integrated Freight & Logistics (US) | Menaik | Menurun |
Integrated Freight & Logistics (Global) | Bercampur | Menurun | |
Stok | Lakeside Holding Limited | - | - |
AISkor Stockmoo
Konsensus Penganalisis | 2.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 0.5 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | -2.0 |
Purata | 0.75 |
Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services. |
|
Sektor | Industrials |
Industri | Integrated Freight & Logistics |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 76.01% |
% Dimiliki oleh Institusi | 0.19% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
17 Dec 2024 | Pengumuman | Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary |
03 Dec 2024 | Pengumuman | Lakeside Holding to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference |
25 Nov 2024 | Pengumuman | Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts |
15 Nov 2024 | Pengumuman | LAKESIDE HOLDING PROVIDES FIRST QUARTER OF FISCAL YEAR 2025 RESULTS |
11 Nov 2024 | Pengumuman | Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd. |
01 Oct 2024 | Pengumuman | Lakeside Holding Reports Impressive 42% Revenue Growth for Fiscal Year 2024 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2024 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |